The global protein therapeutics market depends greatly on the sales from insulin and insulin analogues, as the demand for these therapies are high compared to therapies for other diseases. The segment was not only able to weather the effects of the recent economic downturn, but has also picked up pace since the recovery period started. This has been possible due to factors, such as increasing prevalence of diabetes, improving affordability of populations around the world, and the introduction of painless and convenient methods of insulin delivery attracting the consumers. Backed by these supportive factors, the global insulin market is expected to grow at a CAGR of around 18% during 2012-2014, according to our new research report “Global Protein Therapeutics Market Analysis”.